Abstract
Inappropriate prescribing in older people is a common condition associated with significant morbidity, mortality, and financial costs. Medication use increases with age, and this, in conjunction with an increasing disease burden, is associated with adverse drug reactions. This review outlines why older people are more likely to develop adverse drug reactions and how common the problem is. The use of different tools to identify and measure the problem is reviewed. Common syndromes seen in older adults (eg, falling, cognitive impairment, sleep disturbance) are considered, and recent evidence in relation to medication use for these conditions is reviewed. Finally, we present a brief summary of significant developments in the recent literature for those caring for older people.
Similar content being viewed by others
References and Recommended Reading
Golden AG, Preston RA, Barnett SD, et al.: Inappropriate prescribing in homebound older adults. J Am Geriatr Soc 1999, 47:948–953
O’Connor K, O’Mahony D: Drugs and ageing. In Medicine for Older Patients: Cases and Practice. Edited by Liston R, Mulkerrin EC. Dublin, Ireland: Eireann Healthcare Publications; 2003:205.
Kaufman DW, Kelly JP, Rosenberg L, et al.: Recent patterns of medication use in the ambulatory adult population of the United States: the Slone Survey. JAMA 2002, 287:337.
Everitt DE, Avorn J: Drug prescribing for the elderly. Arch Intern Med 1986, 146:2393–2396.
Mangoni AA, Jackson SH: Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003, 57:6–14.
Hunt CM, Westerkam WR, Stave GM: Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992, 44:275.
Swift CG, Ewen JM, Clarke P, Stephenson IH: Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. Br J Clin Pharmacol 1985, 20:111–118.
Maixner SM, Mellow AM, Tandon R: The efficacy, safety and tolerability of antipsychotics in the elderly. J Clin Psychiatry 1999, 60:29–41.
Col N, Fanale JE, Kronholm P: The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990, 150:841–845.
Hanlon JT, Schmader KE, Kornkowski MJ, et al.: Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997, 45:945–948.
Lindley CM, Tully MP, Paramsothy V, et al.: Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992, 21:294–300.
Cooper JW: Adverse drug reaction-related hospitalizations of nursing-facility patients: a 4 year study. South Med J 1999, 92:485–490.
Fick DM, Cooper JW, Wade WE, et al.: Updating the Beers criteria for potentially inappropriate medication use in older adults—results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716–2724.
McLeod PJ, Huang AR, Tamblyn RN, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997, 156:385–391.
Naugler CT, Brymer C, Stolee P, Arcese ZA: Development and validation of an improved prescribing for the elderly tool. Can J Clin Pharmacol 2000, 7:103–107.
Laroche ML, Charmes JP, Merle L: Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007, 63:725–731.
Oborne CA, Hooper R, Swift CG, Jackson SH: Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003, 32:102–108.
Liu GG, Christensen DB: The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002, 42:847–857.
Pitkala KH, Strandberg TE, Tilvis RS: Inappropriate drug prescribing in home-dwelling elderly patients: a population based survey. Arch Intern Med 2002, 162:1707–1712.
Hanlon JT, Schmader KE, Samsa GP, et al.: A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992, 45:1045–1051.
Jeffrey S, Ruby C, Tverlisky J, et al.: Effect of an interdisciplinary team on suboptimal prescribing in a long-term care facility. Consult Pharm 1999, 14:1386–1391.
Hanlon JT, Artz MB, Pieper CF, et al.: Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004, 38:9–14.
Higashi T, Shekelle PG, Solomon DH: The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004, 140:714–720.
Spinewine A, Schmader KE, Barber N, et al.: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007, 370:173–184.
Lord SR, Anstey KJ, Williams P, et al.: Psychoactive medication use, sensory motor function and falls in older women. Br J Clin Pharmacol 1995, 39:227–234.
Souchet E, Lapeyre-Mestre M, Montastruc JL: Drug related falls: a study in the French Pharmacovigilance database. Pharmacoepidemiol Drug Saf 2005, 14:11–16.
Kamal-Bahl SJ, Stuart BC, Beers MH: Propoxyphene use and risk for hip fracture in older adults. Am J Geriatr Pharmacother 2006, 4:219–226.
Crotty M, Rowett D, Spurling L, et al.: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004, 2:25–64.
Herzog AR, Fultz NH: Prevalence and incidence of urinary incontinence in community dwelling populations. J Am Geriatr Soc 1990, 38:273–281.
Wagner TH, Hu TW: Economic costs of urinary incontinence in 1995. Urology 1998, 51:355–361.
Hay-Smith J, Herbison P, Ellis G, et al.: Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 2005, 3:CD005429.
Gill SS, Mamdani M, Naglie G, et al.: A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 2005, 165:808–813.
Gahimer J, Wernicke J, Yalcin I, et al.: A retrospective pooled analysis of duloxetine safety in 23,983 subjects. Curr Med Res Opin 2007, 23:175–184.
Wang PS, Schneeweiss S, Avorn J, et al.: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335–2341.
Bullock R: Treatment of behavioral and psychiatric symptoms in dementia: implications of recent safety warnings. Curr Med Res Opin 2005, 21:1–10.
Zanocchi M, Tibaldi V, Amati D, et al.: Adverse drug reactions as a cause of visits to the emergency department: incidence, features and outcome [in Italian]. Recenti Prog Med 2006, 97:381–388.
Galatti L, Giustini SE, Sessa A, et al.: Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. Pharmacol Res 2005, 51:211–216.
Karacan I, Thornby JT, Williams RL: Sleep disturbance: a community survey. In Sleep/Wake Disorders: A Natural History, Epidemiology and Long Term Evolution. Edited by Guilleminault C, Lugaresi E. New York: Raven Press; 1983:37–60.
Huang WF, Lai IC: Potentially inappropriate prescribing for insomnia in elderly outpatients in Taiwan. Int J Clin Pharmacol Ther 2006, 44:335–342.
Swegle JM, Logemann C: Management of common opioid side effects. Am Fam Physician 2006, 74:1347–1354.
Heading R, Bardhan K, Hollerbach S, et al.: Systematic review: the safety and tolerability of pharmacological agents for treatment of irritable bowel syndrome—a European perspective. Aliment Pharmacol Ther 2006, 24:207–236.
Currow DC, Stevenson JP, Abernethy AP, et al.: Prescribing in palliative as death approaches. J Am Geriatr Soc 2007, 55:590–595.
Ratz Bravo AE, Tchambaz L, Krahenbuhl-Melcher A, et al.: Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy. Drug Saf 2005, 28:263–275.
Muldoon MF, Ryan CM, Sereika SM, et al.: Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 2004, 117:823–829.
Tatley M, Savage R: Psychiatric adverse reactions with statins, fibrates and ezetimibe. Drug Saf 2007, 30:195–201.
Ko DT, Juurlink DN, Mamdani MM, et al.: Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. J Card Fail 2006, 12:205–210.
Gallelli L, Colosimo M, Pirritano D, et al.: Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Investig 2007, 27:115–122.
Bresalier RS, Sandler RS, Quan H, et al.: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352:1092–1102.
Nissen SE, Wolski K: Effects of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457–2471.
Home PD, Pocock SJ, Beck-Nielsen H, et al.: Rosiglitazone evaluated for cardiovascular outcomes-an interim analysis. N Engl J Med 2007, 357:28–38.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barry, P.J., Gallagher, P. & Ryan, C. Inappropriate prescribing in geriatric patients. Curr Psychiatry Rep 10, 37–43 (2008). https://doi.org/10.1007/s11920-008-0008-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11920-008-0008-3